Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biomolecular soft nucleophiles are chemical functional groups within biological molecules, such as the sulfhydryl (-SH) groups of cysteine and glutathione, characterized by high polarizability and low electronegativity (Pearson, R. G., 1963, J. Am. Chem. Soc.). These nucleophiles are vital for cellular homeostasis, participating in redox signaling, enzymatic catalysis, and the detoxification of electrophilic xenobiotics (Forman, H. J., et al., 2009, Mol. Aspects Med.). In pharmacology, they are the primary sites for covalent drug attachment; for instance, targeted covalent inhibitors (TCIs) like ibrutinib form bonds with specific cysteine residues to inhibit kinase activity (Singh, J., et al., 2011, Nat. Rev. Drug Discov.). However, the high reactivity of these groups also poses toxicological risks, as non-specific electrophilic attack can deplete glutathione or form immunogenic protein adducts (Liebler, D. C., 2008, Chem. Res. Toxicol.). Consequently, while they are essential for drug efficacy in certain contexts, they also represent a major pathway for drug-induced toxicity and off-target effects.
Covalent modification of nucleophilic residues (primarily cysteine) via Michael addition or nucleophilic substitution to inhibit enzyme activity or modulate cellular redox state.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biomolecular soft nucleophiles.